Cervical Cancer Treatment Market Size, Share & Trends Analysis Report By Type (SCC, Adenocarcinoma), By Product (Prevention, Treatment), By Distribution Channel (Online, Hospital Pharmacies), And Segment Forecasts, 2018 - 2025

Table of Contents

Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Scope and Assumptions
1.3 List of Tables
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation
Chapter 4 Market Definitions
4.1 Disease Primer and Epidemiology
4.2 Market Segmentation
Chapter 5 Industry Outlook
5.1 Market Variable Analysis
5.1.1 High Disease Prevalence
5.1.2 Proactive government initiatives
5.1.3 Availability of targeted therapies
5.1.4 Increase in R&D funding for cancer research
5.2 Market Restraint Analysis
5.2.1 Lack of consumer awareness
5.2.2 High cost of treatment
Chapter 6 Business Environment Analysis
6.1 SWOT Analysis; By factor (political & legal, economic and technological)
6.2 Porter’s Five Forces Analysis
6.3 Pipeline Analysis
Chapter 7 Type BusinessAnalysis
7.1 Cervical Cancer Treatment market: Type Movement Analysis
7.2 Squamous Cell Carcinoma
7.2.1 Squamous Cell Carcinoma market estimates and forecast, 2014 - 2025
7.3 Adenocarcinoma
7.3.1 Adenocarcinoma market estimates and forecast, 2014 - 2025
7.4 Adenosquamous Carcinoma
7.4.1 Adenosquamous Carcinoma market estimates and forecast, 2014 - 2025
Chapter 8 ProductBusinessAnalysis
8.1 Cervical Cancer Treatment market: Product Movement Analysis
8.2 Gardasil/Gardasil 9
8.2.1 Gardasil/Gardasil 9 market estimates and forecast, 2014 - 2025
8.3 Cervarix
8.3.1 Cervarix market estimates and forecast, 2014 - 2025
8.4 Avastin
8.4.1 Avastin market estimates and forecast, 2014 - 2025
8.5 Keytruda
8.5.1 Keytruda market estimates and forecast, 2014 - 2025
8.6 Generics
8.6.1 Generics market estimates and forecast, 2014 - 2025
8.7 Others
8.7.1 others market estimates and forecast, 2014 - 2025
Chapter 9 Distribution Channel Business Analysis
9.1 Cervical Cancer Treatment market: Distribution Channel Movement Analysis
9.2 Hospital Pharmacies
9.2.1 Hospital pharmacies market estimates and forecast, 2014 - 2025
9.3 Retail Pharmacies
9.3.1 Retail pharmacies market estimates and forecast, 2014 - 2025
9.4 Online Pharmacies
9.4.1 Online pharmacies market estimates and forecast, 2014 - 2025
Chapter 10 Regional Business Analysis
10.1 Cervical Cancer Treatment Market: Regional Movement Analysis
10.2 North America
10.2.1 North America market estimates and forecast, 2014 - 2025
10.2.2 The U.S.
10.2.2.1 U.S. market estimates and forecast, 2014 - 2025
10.2.3 Canada
10.2.3.1 Canada market estimates and forecast, 2014 - 2025
10.3 Europe
10.3.1 Europe market estimates and forecast, 2014 - 2025
10.3.2 Germany
10.3.3 Germany market estimates and forecast, 2014 - 2025
10.3.4 UK
10.3.5 UK market estimates and forecast, 2014 - 2025
10.4 Asia-Pacific
10.4.1 Asia-Pacific market estimates and forecast, 2014 - 2025
10.4.2 Japan
10.4.2.1 Japan market estimates and forecast, 2014 - 2025
10.4.3 China
10.4.3.1 China market estimates and forecast, 2014 - 2025
10.4.4 India
10.4.4.1 India market estimates and forecast, 2014 - 2025
10.5 Latin America
10.5.1 Latin America market estimates and forecast, 2014 - 2025
10.5.2 Brazil
10.5.2.1 Brazil market estimates and forecast, 2014 - 2025
10.5.3 Mexico
10.5.3.1 Market estimates and forecast, 2014 - 2025
10.6 Middle East and Africa
10.6.1 Middle-East and Africa market estimates and forecast, 2014 - 2025
10.6.2 South Africa
10.6.3 South Africa market estimates and forecast, 2014 - 2025
Chapter 11 Company Profile
11.1 Company Profiles
11.1.1 F.Hoffmann-LA Roche AG
11.1.1.1 Company overview
11.1.1.2 Financial Performance
11.1.1.3 Product benchmarking
11.1.1.4 Strategic initiatives
11.1.2 Merck & Co., Inc.
11.1.2.1 Company overview
11.1.2.2 Financial Performance
11.1.2.3 Product benchmarking
11.1.2.4 Strategic initiatives
11.1.3 GLAXOSMITHKLINE plc
11.1.3.1 Company overview
11.1.3.2 Financial Performance
11.1.3.3 Product benchmarking
11.1.3.4 Strategic initiatives
11.1.4 ALLERGAN
11.1.4.1 Company overview
11.1.4.2 Financial Performance
11.1.4.3 Product benchmarking
11.1.4.4 Strategic initiatives
11.1.5 PFIZER, Inc.
11.1.5.1 Company overview
11.1.5.2 Financial Performance
11.1.5.3 Product benchmarking
11.1.5.4 Strategic initiatives
11.1.6 BIOCON Limited
11.1.6.1 Company overview
11.1.6.2 Financial Performance
11.1.6.3 Product benchmarking
11.1.6.4 Strategic initiatives
11.1.7 Bristol-Myers Squibb
11.1.7.1 Company overview
11.1.7.2 Financial Performance
11.1.7.3 Product benchmarking
11.1.7.4 Strategic initiatives
11.1.8 AstraZeneca
11.1.8.1 Company overview
11.1.8.2 Financial Performance
11.1.8.3 Product benchmarking
11.1.8.4 Strategic initiatives
11.1.9 Eli Lilly and Company
11.1.9.1 Company Overview
11.1.9.2 . FINANCIAL PERFORMANCE
11.1.9.3 Product Benchmarking
11.1.9.4 Strategic Initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 Cervical Cancer Epidemiology - 2017
Table 3 Cervical Cancer - Pipeline Intelligence
Table 4 Product Portfolio: Gardasil
Table 5 Product Portfolio: Cervarix
Table 6 Product Portfolio: Avastin
Table 7 Product Portfolio: Keytruda
Table 8 Product Portfolio: Generics
Table 9 North America Cervical Cancer Market, by Type, 2014 - 2025 (USD Million)
Table 10 North America Cervical Cancer Market, by Product, 2014 - 2025 (USD Million)
Table 11 North America Cervical Cancer Market, by Distribution Channel, 2014 - 2025 (USD Million)
Table 12 U.S. Cervical Cancer Market, by Type, 2014 - 2025 (USD Million)
Table 13 U.S. Cervical Cancer Market, by Product, 2014 - 2025 (USD Million)
Table 14 U.S. Cervical Cancer Market, by Distribution Channel, 2014 - 2025 (USD Million)
Table 15 Canada Cervical Cancer Market, by Type, 2014 - 2025 (USD Million)
Table 16 Canada Cervical Cancer Market, by Product, 2014 - 2025 (USD Million)
Table 17 Canada Cervical Cancer Market, by Distribution Channel, 2014 - 2025 (USD Million)
Table 18 Europe Cervical Cancer Market, by Type, 2014 - 2025 (USD Million)
Table 19 Europe Cervical Cancer Market, by Product, 2014 - 2025 (USD Million)
Table 20 Europe Cervical Cancer Market, by Distribution Channel, 2014 - 2025 (USD Million)
Table 21 U.K. Cervical Cancer Market, by Type, 2014 - 2025 (USD Million)
Table 22 U.K. Cervical Cancer Market, by Product, 2014 - 2025 (USD Million)
Table 23 U.K. Cervical Cancer Market, by Distribution Channel, 2014 - 2025 (USD Million)
Table 24 Germany Cervical Cancer Market, by Type, 2014 - 2025 (USD Million)
Table 25 Germany Cervical Cancer Market, by Product, 2014 - 2025 (USD Million)
Table 26 Germany Cervical Cancer Market, by Distribution Channel, 2014 - 2025 (USD Million)
Table 27 Latin America Cervical Cancer Market, by Type, 2014 - 2025 (USD Million)
Table 28 Latin America Cervical Cancer Market, by Product, 2014 - 2025 (USD Million)
Table 29 Latin America Cervical Cancer Market, by Distribution Channel, 2014 - 2025 (USD Million)
Table 30 Brazil Cervical Cancer Market, by Type, 2014 - 2025 (USD Million)
Table 31 Brazil Cervical Cancer Market, by Product, 2014 - 2025 (USD Million)
Table 32 Brazil Cervical Cancer Market, by Distribution Channel, 2014 - 2025 (USD Million)
表33墨西哥宫颈癌市场,按类型,2014 - 2025 (USD Million)
Table 34 Mexico Cervical Cancer Market, by Product, 2014 - 2025 (USD Million)
Table 35 Mexico Cervical Cancer Market, by Distribution Channel, 2014 - 2025 (USD Million)
Table 36 Asia Pacific Cervical Cancer Market, by Type, 2014 - 2025 (USD Million)
Table 37 Asia Pacific Cervical Cancer Market, by Product, 2014 - 2025 (USD Million)
Table 38 Asia Pacific Cervical Cancer Market, by Distribution Channel, 2014 - 2025 (USD Million)
Table 39 Japan Cervical Cancer Market, by Type, 2014 - 2025 (USD Million)
Table 40 Japan Cervical Cancer Market, by Product, 2014 - 2025 (USD Million)
Table 41 Japan Cervical Cancer Market, by Distribution Channel, 2014 - 2025 (USD Million)
Table 42 China Cervical Cancer Market, by Type, 2014 - 2025 (USD Million)
Table 43 China Cervical Cancer Market, by Product, 2014 - 2025 (USD Million)
Table 44 China Cervical Cancer Market, by Distribution Channel, 2014 - 2025 (USD Million)
Table 45 India Cervical Cancer Market, by Type, 2014 - 2025 (USD Million)
Table 46 India Cervical Cancer Market, by Product, 2014 - 2025 (USD Million)
Table 47 India Cervical Cancer Market, by Distribution Channel, 2014 - 2025 (USD Million)
表48 MEA宫颈癌市场,按类型,2014年- 2025 (USD Million)
Table 49 MEA Cervical Cancer Market, by Product, 2014 - 2025 (USD Million)
Table 50 MEA Cervical Cancer Market, by Distribution Channel, 2014 - 2025 (USD Million)
Table 51 South Africa Cervical Cancer Market, by Type, 2014 - 2025 (USD Million)
Table 52 South Africa Cervical Cancer Market, by Product, 2014 - 2025 (USD Million)
Table 53 South Africa Cervical Cancer Market, by Distribution Channel, 2014 - 2025 (USD Million)

List of Figures

Fig. 1 Cervical cancer treatment market snapshot
Fig. 2 Cervical cancer treatment market segmentation
Fig. 3 Current disease prevalence - 2017
Fig. 4 Cervical cancer treatment market - driver impact
Fig. 5 Cervical cancer treatment market - restraint impact
Fig. 6 SWOT Analysis, By Factor (Political & legal Economic and technological)
Fig. 7 Porter’s Five Forces Analysis
Fig. 8 Cervical Cancer Treatment market: Type outlook and key takeaways
Fig. 9 Cervical Cancer Treatment market: Type Movement Analysis
Fig. 10 Squamous cell carcinoma market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 11 Adenocarcinoma market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 12 Adenosquamous carcinoma market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 13 Cervical Cancer Treatment market: Product outlook and key takeaways
Fig. 14 Cervical Cancer Treatment market: Product Movement Analysis
Fig. 15 Gardasil/Gardasil 9 market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 16 Cervarix market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 17 Avastin market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 18 Keytruda market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 19 Generics market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 20 Others market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 21 Cervical Cancer Treatment market: Distribution Channel outlook and key takeaways
Fig. 22 Cervical Cancer Treatment Market: Distribution Channel Movement Analysis
Fig. 23 Hospital Pharmacies market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 24 Retail Pharmacies market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 25 Online Pharmacies market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 26 Cervical Cancer Treatment Market: Regional Outlook and Key Takeaways
Fig. 27 Cervical Cancer Treatment market: Regional movement analysis
Fig. 28 North America
Fig. 29 North America. market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 30 U.S. market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 31 Canada market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 32 Europe
图33个欧洲市场估计和预测,2014年- 2025 (USD Million)
Fig. 34 Germany market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 35 U.K. market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 36 Asia-Pacific
Fig. 37 Asia-Pacific market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 38 Japan market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 39 China. market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 40 India market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 41 Latin America
Fig. 42 Latin America market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 43 Brazil market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 44 Mexico market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 45 Middle East & Africa
Fig. 46 MEA market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 47 South Africa market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 48 Company profile